These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 25183017

  • 1. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM, Otoni CC, Jergens AE, Grützner N, Suchodolski JS, Steiner JM.
    Vet Immunol Immunopathol; 2014 Oct 15; 161(3-4):184-92. PubMed ID: 25183017
    [Abstract] [Full Text] [Related]

  • 2. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM, Grellet A, Allenspach K, Lecoindre P, Day MJ, Priestnall SL, Toresson L, Procoli F, Grützner N, Suchodolski JS, Steiner JM.
    Vet Immunol Immunopathol; 2014 Apr 15; 158(3-4):156-66. PubMed ID: 24518653
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association between serum soluble receptor for advanced glycation end-products (RAGE) deficiency and severity of clinicopathologic evidence of canine chronic inflammatory enteropathy.
    Cabrera-García AI, Suchodolski JS, Steiner JM, Heilmann RM.
    J Vet Diagn Invest; 2020 Sep 15; 32(5):664-674. PubMed ID: 32715975
    [Abstract] [Full Text] [Related]

  • 5. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
    Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Magloire LK, Thung S, Fairchild T, Buhimschi CS.
    Am J Obstet Gynecol; 2007 Feb 15; 196(2):181.e1-13. PubMed ID: 17306673
    [Abstract] [Full Text] [Related]

  • 6. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
    Meijer B, Hoskin T, Ashcroft A, Burgess L, Keenan JI, Falvey J, Gearry RB, Day AS.
    J Crohns Colitis; 2014 Jun 15; 8(6):513-20. PubMed ID: 24291021
    [Abstract] [Full Text] [Related]

  • 7. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS.
    Scand J Gastroenterol; 2007 Nov 15; 42(11):1321-31. PubMed ID: 17852869
    [Abstract] [Full Text] [Related]

  • 8. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
    Kim HS, Chung W, Kim AJ, Ro H, Chang JH, Lee HH, Jung JY.
    Nephrology (Carlton); 2013 Dec 15; 18(12):777-82. PubMed ID: 24124651
    [Abstract] [Full Text] [Related]

  • 9. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H, Hirono K, Ichida F, Vogl T, Ye F, Yanlin X, Saito K, Uese K, Miyawaki T, Viemann D, Roth J, Foell D.
    Arthritis Rheum; 2007 Dec 15; 56(12):4174-81. PubMed ID: 18050248
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
    Chen YS, Yan W, Geczy CL, Brown MA, Thomas R.
    Arthritis Res Ther; 2009 Dec 15; 11(2):R39. PubMed ID: 19284577
    [Abstract] [Full Text] [Related]

  • 11. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
    Myles A, Viswanath V, Singh YP, Aggarwal A.
    J Rheumatol; 2011 Sep 15; 38(9):1994-9. PubMed ID: 21724696
    [Abstract] [Full Text] [Related]

  • 12. Fecal S100A12 concentration predicts a lack of response to treatment in dogs affected with chronic enteropathy.
    Heilmann RM, Volkmann M, Otoni CC, Grützner N, Kohn B, Jergens AE, Steiner JM.
    Vet J; 2016 Sep 15; 215():96-100. PubMed ID: 27017054
    [Abstract] [Full Text] [Related]

  • 13. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N, Leurs P, Qureshi AR, Bruchfeld A, Anderstam B, Heimburger O, Bárány P, Stenvinkel P, Lindholm B.
    Nephrol Dial Transplant; 2015 Jan 15; 30(1):84-91. PubMed ID: 25074436
    [Abstract] [Full Text] [Related]

  • 14. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK, Park S, Lee MJ, Song YR, Han SH, Kim SG, Kang SW, Choi KH, Kim HJ, Yoo TH.
    Atherosclerosis; 2012 Jan 15; 220(1):208-14. PubMed ID: 21906738
    [Abstract] [Full Text] [Related]

  • 15. S100A12 and soluble receptor for advanced glycation end products levels during human severe sepsis.
    Achouiti A, Föll D, Vogl T, van Till JW, Laterre PF, Dugernier T, Wittebole X, Boermeester MA, Roth J, van der Poll T, van Zoelen MA.
    Shock; 2013 Sep 15; 40(3):188-94. PubMed ID: 23846410
    [Abstract] [Full Text] [Related]

  • 16. Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.
    Heilmann RM, Nestler J, Schwarz J, Grützner N, Ambrus A, Seeger J, Suchodolski JS, Steiner JM, Gurtner C.
    Vet Immunol Immunopathol; 2019 May 15; 211():64-74. PubMed ID: 31084897
    [Abstract] [Full Text] [Related]

  • 17. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, Ehrchen J, Heidemann J, Borody T, Roth J, Clancy R.
    J Pathol; 2008 Oct 15; 216(2):183-92. PubMed ID: 18729068
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M, Hörauf A, Bilzer T.
    Berl Munch Tierarztl Wochenschr; 2006 Oct 15; 119(11-12):493-505. PubMed ID: 17172138
    [Abstract] [Full Text] [Related]

  • 20. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease.
    Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J.
    Gut; 2003 Jun 15; 52(6):847-53. PubMed ID: 12740341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.